SCHEMBL2555503

SCHEMBL2555503

CCOC(OCC)[SiH2]CCC(C)N

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
OPRM1 P35372 1/20 0.36
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16422290 0.81 LMNA (0.32) LMNA
SCHEMBL375456 0.80 LMNA (0.35) LMNATHRB
SCHEMBL732361 0.80 LMNA (0.35) LMNATHRB
SCHEMBL331066 0.80 THRB (0.42) LMNATHRB
SCHEMBL20677333 0.79 MEN1 (0.30)
SCHEMBL2552509 0.79 OPRM1 (0.32) OPRM1
SCHEMBL17891764 0.78 ALDH1A1 (0.32)
SCHEMBL9326209 0.77 CHRNB2 (0.33) LMNA
SCHEMBL1847272 0.76 THRB (0.35) LMNATHRB
SCHEMBL557200 0.75 THRB (0.38) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570899-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2026-03-10 US disclosed
CN-115678542-B Quaternary nanostructure based on bright silver 昭荣化学工业株式会社 2024-12-31 CN disclosed
US-20240263069-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES SHOEI CHEMICAL INC. (JP) 2024-08-08 US disclosed
US-11970646-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2024-04-30 US disclosed
CN-112724405-B Curing agent mixture 赢创运营有限公司 2024-01-30 CN disclosed
CN-115678542-A Quaternary nanostructure based on bright silver 纳米系统公司 2023-02-03 CN disclosed
EP-3816247-B1 CURING MIXTURE EVONIK OPERATIONS GMBH (DE) 2022-12-07 EP disclosed
CN-113840895-B Quaternary nanostructure based on bright silver 纳米系统公司 2022-11-15 CN disclosed
US-20220228057-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES NANOSYS, INC. (US) 2022-07-21 US disclosed
EP-3973033-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES Nanosys, Inc. (US) 2022-03-30 EP disclosed
US-20160108280-A1 CROSSLINKING OF IPMS ADDUCTS WITH AMINOSILANES EVONIK DEGUSSA GMBH (DE) 2016-04-21 US disclosed
EP-2994495-A1 CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES Evonik Industries AG (DE) 2016-03-16 EP disclosed
US-9266825-B2 Copolymers of isocyanatoalkyltrialkoxysilanes and urethanediols EVONIK DEGUSSA GMBH (DE) 2016-02-23 US disclosed
EP-2905296-B1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols EVONIK DEGUSSA GMBH (DE) 2015-12-23 EP disclosed
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS EVONIK INDUSTRIES AG (DE) 2015-08-13 US disclosed
EP-2905296-A1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols Evonik Degussa GmbH (DE) 2015-08-12 EP disclosed
EP-2552925-B1 PROCESS FOR THE PREPARATION OF SILICON CONTAINING AZODICARBAMIDES EVONIK DEGUSSA GMBH (DE) 2014-07-23 EP disclosed
US-8664370-B2 Process for preparing silicon-containing azodicarbamides EVONIK DEGUSSA GMBH (DE) 2014-03-04 US disclosed
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides EVONIK OPERATIONS GMBH (DE) 2013-01-10 US disclosed
WO-2011120792-A1 PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES EVONIK DEGUSSA GMBH (DE) 2011-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570899-B2 Bright silver based quaternary nanostructures LGALS3, ANXA3, ATXN2L LMNA 3108/4885OPRM1 2012/4885THRB 2016/4885
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides C1R, CA9, CCNB3 LMNA 2541/4885OPRM1 3084/4885THRB 3862/4885
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS ACMSD, OR10J3, CCND2 LMNA 1732/4885OPRM1 968/4885THRB 4056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.